An exploratory study of inhalers and injectors who used black tar heroin

Journal of Maintenance in the Addictions

Volumn 3, Issue 1, 2006, Pages 61-82

  Maxwell, Jane Carlisle ^a,b,c,d   Spence, Richard T ^a,e  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Gulf Coast Addiction Technology Research Center   (United States)

^d SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Black tar heroin; Inhaling; Injecting; Shebanging; Snorting

Indexed keywords

EID: 33746603970     PISSN: 10911332     EISSN: 15407624     Source Type: Journal    
DOI: 10.1300/J126v03n01_06     Document Type: Article

References (34)

1. Breslau, L. (1985). Depressive symptoms, major depression, and generalized anxiety: A Comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatric Research, 15: 219-229.
2. Carpenter, M. J., Chutuape, M.A., & Stitzer, M.L. (1998). Heroin snorters versus injectors: Comparison on drug use and treatment outcome in age-matched samples. Drug and Alcohol Dependence, 53, 11-15.
3. Center for Substance Abuse Treatment (1998). Substance use disorder treatment for people with physical and cognitive disabilities: Treatment improvement protocol series 29. Rockville, MD.
4. Corrigan, J. (2003). Relationship between traumatic brain injury and substance abuse. Retrieved September 12, 2003 from http://www.ohiovalley.org/ abuse/.
5. De Alba, I., Samet, J. H., Saitz, R. (2004). Burden of medical illness in drug- and alcohol-dependent persons without primary care. American Journal on Addictions, 13, 33-45.
6. Des Jarlais, D. C., Casriel, C., Friedman, S. R., & Rosenblum, A. (1992). AIDS and the transition to illicit drug injection-results of a randomized trial prevention program. British Journal of Addiction, 87, 493-398.
7. Drug Enforcement Administration. (2003). 2002 Domestic Monitor Program. (DEA-03057). Washington DC: U. S. Department of Justice.
8. Frank, Blanche. (2002). An overview of heroin trends in New York City: Past, present and future. The Mount Sinai Journal of Medicine, 67, 340-346.
9. Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., & Strathdee, S. A. (2002). High-risk behaviours associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug and Alcohol Dependence, 66, 189-198.
10. Gossop, M., Powis, B., Griffiths, P., & Strang (1994). Multiple risks for HIV and hepatitis B infection among heroin users. Drug and Alcohol Review, 13, 293-300.
11. Gossop, M., Steward, D., Marsden, J., Kidd, T., & Strang, J. (2004). Changes in route of drug administration among continuing heroin users: Outcomes 1 year after intake to treatment. Addictive Behaviors, 29, 1085-1094.
12. Griffiths, P., Gossop, M., Powis, B., & Strang, J. (1992). Extent and nature of transitions of route among heroin addicts in treatment-preliminary data from the Drug Transitions Study. British Journal of Addiction, 87, 485-491.
13. Griffiths, P., Gossop, M., Powis, B., & Strang, J. (1994). Transitions in patterns of heroin administration: A study of heroin chasers and heroin injectors, Addiction, 89, 301-309.
14. Kelley, M. S. & Chitwood, D. D. (2004). Effects of drug treatment for heroin snifffers: a protective factor against moving to injection? Social Science and Medicine, 58, 2083-2092.
15. Kerber, L. (2000). Substance use among male inmates: Texas Department of Criminal Justice-Institutional Division, 1998. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
16. Kerber, L. (2001a). Substance use among female inmates: Texas Department of Criminal Justice-State Jail Division, 1998. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
17. Kerber, L. (2001b). Substance use among male inmates: Texas Department of Criminal Justice-State Jail Division, 1998. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
18. Kerber, L. & Harris, R. (2001). Substance use among female inmates entering the Texas Department of Criminal Justice-Institutional Division, 1998. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
19. Kerber, L., Maxwell, J., & Wallisch, L. (2001). Substance use among offenders entering the Texas Department of Criminal Justice-Substance Abuse Felony Punishment Facilities, 1998-2000. Austin, TX: Texas Commission on Alcohol and Drug Abuse.
20. Korman, M., Trimboli, F., & Semler, I. (1980). A comparative evaluation of 162 inhalant users. Addictive Behaviors, 5, 143-152.
21. Lambert, R. C. (1998). The effects of treatment for opiate addiction on health promoting behavior. Journal of Maintenance in the Addictions, 1, 45-66.
22. Maddux, J.F. & Desmond, D. P. (1981). Careers of Opioid Users. New York: Praeger Press.
23. Maxwell, J. C., Bohman, T., & Spence, R. T. (2004). Differences in characteristics of heroin inhalers and heroin injectors at admission to treatment: A preliminary study using a large database of client records. Substance Use and Misuse, 39 (6), 989-1008.
24. McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved evaluation instrument for substance abuse patients: the Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26-33.
25. National Institute on Drug Abuse. (1987). Black tar heroin. In Drug Abuse Trends and Research Issues, Community Epidemiology Work Group Proceedings, December 1986. Rockville, MD: National Institute on Drug Abuse, III-1-9.
26. National Institute on Drug Abuse (2004). Lapse or relapse to drug abuse and other chronic conditions, RFA Number: RFA-DA-05-004. Downloaded from http://www.nida.nih.gov, November 24, 2004.
27. Neaigus, A., Miller, M., Friedman, S. R., Hagen, D.L., Sifaneck, S. J., Ildefonso, G., & Des Jarlais, D. C. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction, 96, 847-860.
28. Nunes, E.V. & Levin, F.R. (2004). Treatment of depression in patients with alcohol and or other drug dependence: a meta-analysis. Journal of the American Medical Association, 291 (15): 1887-1896.
29. Rosenberg, N., Spitz, M., Filley, C., Davis, K., & Schaumburg, H. (1988). Central nervous system effects of chronic toluene abuse-clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicology and Teratology, 10, 489-495.
30. Strang, J., Des Jarlais, D. C., Griffiths, P., & Gossop, M. (1992). The study of transitions in the route of drug use: The route from one route to another. British Journal of Addiction, 87, 473-483.
31. Strang, J., Griffiths, P., & Gossop, M. (1997b). Heroin in the United Kingdom: Different forms, different origins, and the relationship to different routes of administration. Drug and Alcohol Review, 16, 329-337.
32. Strang, J., Griffiths, P., Powis, B., Abbey, J., & Gossop, M. (1997a). How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug and Alcohol Dependence, 46, 115-118.
33. Strauss, S. M., Astone, J. M., Des Jarlais, D., Hagan, H. (2004). A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug and Alcohol Dependence, 73, 227-236.
34. Volkow N. D., Fowler, J. S., Wang G-J. (2003). The addicted human brain: insights from imaging studies. The Journal of Clinical Investigation, 111(10): 1444-1451.